Vivex Biomedical and Arthrex signed a new multi-year agreement expanding the breadth of Vivex’s products for Arthrex’s distribution.
This expanded relationship follows the co-development and distribution of BioCartilage by Arthrex and Vivex Biomedical, through its University of Miami Tissue Bank. BioCartilage provides a scaffold over a microfractured defect, offering a tissue network that may signal autologous cellular interactions to support tissue healing.
The two companies each signed agreements with other partners in 1Q16:
LifeNet Health and Arthrex signed a new long-term agreement to provide allograft implants and instrumentation to surgeons.
Xtant Medical and Vivex entered into a distribution relationship to commercialize OsteoVive™ viable cell allograft.
Vivex Biomedical and Arthrex signed a new multi-year agreement expanding the breadth of Vivex's products for Arthrex's distribution.
This expanded relationship follows the co-development and distribution of BioCartilage by Arthrex and Vivex Biomedical, through its University of Miami Tissue Bank. BioCartilage provides a scaffold over a...
Vivex Biomedical and Arthrex signed a new multi-year agreement expanding the breadth of Vivex’s products for Arthrex’s distribution.
This expanded relationship follows the co-development and distribution of BioCartilage by Arthrex and Vivex Biomedical, through its University of Miami Tissue Bank. BioCartilage provides a scaffold over a microfractured defect, offering a tissue network that may signal autologous cellular interactions to support tissue healing.
Copy to clipboard 
